App Development



App development Proposal template

Sample Applications & More  January 28, 2022 – 12:25 am
Mobile App Development Proposal Template

Several investigators have graciously agreed to let us post their exceptional applications online.

We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.

We selected these applications as sound examples of good grantsmanship. That said, time has passed since these grantees applied, and so the samples may not reflect the latest application format or rules. Therefore, always follow your funding opportunity's instructions for application format. We post new samples periodically.

Note: The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.

R01 Sample Applications and Summary Statements

PI and Grantee Institution Application Resources

William Faubion, Ph.D., of the Mayo Clinic Rochester
“Inflammatory cascades disrupt Treg function through epigenetic mechanisms”

Chengwen Li, Ph.D., and Richard Samulski, Ph.D., of University of North Carolina at Chapel Hill
“Enhance AAV Liver Transduction with Capsid Immune Evasion”

Mengxi Jiang, Ph.D., of University of Alabama at Birmingham
“Intersection of polyomavirus infection and host cellular responses”

R03 Sample Applications and Summary Statements

The small grant (R03) supports new research projects that can be carried out in a short period of time with limited resources. They are awarded for up to two years and are not renewable. R03s are not intended for new investigators.

Martin Karplus, Ph.D., of Harvard University
"Modeling atomic structure of the EmrE multidrug pump to design inhibitor peptides"

Chad A. Rappleye, Ph.D., of Ohio State University
"Forward genetics-based discovery of Histoplasma virulence genes"

R21 Sample Applications and Summary Statements

Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.

Steven W. Dow, DVM, Ph.D., of Colorado State University, Fort Collins
"Mechanisms of enteric Burkholderia psuedomallei infection"

Joseph M. McCune, MD, Ph.D., of the University of California, San Francisco
"Human immune system layering and the neonatal response to vaccines"

Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute
"Ribosome profiling of Trypanosoma brucei"

Howard T. Petrie, of Scripps Florida
"Lymphoid signals for stromal growth and organization in the thymus."

Michael N. Starnbach, Ph.D., of Harvard University Medical School
"Alteration of host protein stability by Legionella"

R21/R33 Sample Application and Summary Statement

The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.

Stephen Dewhurst, Ph.D., of the University of Rochester
"The semen enhancer of HIV infection as a novel microbicide target"

R41, R42, R43, and R44 – Small Business Sample Applications

The SBIR (R43/R44) and STTR (R41/R42) programs support domestic small businesses to engage in research and development with the potential for commercialization. Read more about Small Business Programs.

Source: www.niaid.nih.gov

Related posts:

  1. App development company names
  2. App development Project Management
  3. App development cost Calculator
  4. App development cost estimate
  5. App development contract template